Imagine being told that something as simple as your daily meals could hold back the march of a deadly cancer—fascinating, right? But what if that same insight sparks a heated debate on whether lifestyle tweaks are enough against serious diseases like multiple myeloma?
Diving into the world of nutrition and oncology, recent research hints that embracing a high-fiber, plant-based eating plan might slow down the advancement of multiple myeloma (MM) in people dealing with its early warning signs, while also boosting metabolism and strengthening the immune system.
A study featured in Cancer Discovery revealed that such a diet could postpone the progression of MM among individuals with monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). This comes from the NUTRIVENTION clinical trial (NCT04920084), where participants experienced enhancements in their metabolism, gut microbiome makeup, heightened antitumor immunity, and even slowed tumor expansion.1,2 For beginners, think of the microbiome as the trillions of tiny microbes living in your gut that play a huge role in digestion and overall health—much like a bustling community of helpful neighbors.
But here's where it gets controversial: Can a diet really outsmart cancer cells, or is this just wishful thinking amid complex medical treatments?
To understand this better, let's break down multiple myeloma and its journey. MM is a form of cancer originating from plasma cells, which are specialized white blood cells made in the bone marrow. These cells normally produce antibodies to fight infections, but in MM, they multiply uncontrollably, leading to issues like bone pain, fatigue, and weakened immunity. Often, MM evolves from precursor stages like MGUS and SMM, which might stay dormant or escalate to full-blown cancer.
MGUS represents an initial, often symptom-free phase characterized by abnormal M proteins in the blood, with roughly a 1% chance each year of advancing to MM. SMM sits in the middle, carrying a steeper risk—about 10% annually, particularly in the first five years post-diagnosis—and differs genetically from MM.3 If you're worried about your condition worsening to MM, proactive steps like dietary changes could offer a buffer against progression.
And this is the part most people miss: The trial didn't just look at cancer markers—it explored how practical and sustainable this diet really is for everyday folks.
The NUTRIVENTION trial examined the viability of a high-fiber, plant-based diet for 20 overweight participants with MGUS or SMM. Researchers assessed practicality through weight loss and adherence, while feasibility hinged on quality-of-life improvements and tweaks to key risk factors, such as BMI, insulin resistance, microbiome variety, and immune elements like inflammation and specific immune cell types. For three months, participants followed the diet, supported by health coaching for six months.2
“The approach we're studying focuses on whole-food, plant-based meals—essentially vegan, prioritizing unprocessed foods and avoiding highly refined items,” shared Francesca Castro, MS, RDN, CDN, a dietitian-nutritionist at Memorial Sloan Kettering (MSK) Cancer Center. “We stress aiming for progress over flawlessness. Switching to this way of eating is a big shift, and not everyone can jump in fully right away. We're here to guide you through it step by step, making it feel achievable.”4 Imagine swapping a burger for a hearty lentil stew loaded with vegetables and whole grains—it's not just about restriction; it's about nourishing your body with fiber-rich options that support gut health.
Over a year, the trial participants shed pounds, enjoyed better quality of life, and saw positive shifts in metabolic indicators like cholesterol and insulin levels. They also had enhancements in immune and microbiome health markers. Notably, two individuals even reversed their disease trajectory. These results mirrored findings in Vk*MYC mice mimicking the myeloma precursor state, where a high-fiber diet stalled progression via metabolic and microbiome improvements, ramping up short-chain fatty acids that revived anti-cancer immunity and curbed tumor growth. Crucially, these benefits occurred regardless of calorie cuts or weight reduction.1,4
“There’s solid evidence that plant-based diets aid in managing weight, diabetes, heart issues, kidney problems, and even autoimmune conditions,” noted Urvi Shah, MD, a myeloma expert at MSK Cancer Center. “They likely influence MGUS and SMM progression too. For instance, elevated BMI ups the risk of these conditions, and someone with a high BMI and MGUS or SMM is twice as likely to advance to MM compared to those with a normal BMI.”4 To illustrate, picture someone incorporating daily fiber from sources like beans, oats, and leafy greens—potentially lowering inflammation and supporting immune balance in ways that go beyond traditional medicine.
Ultimately, the study champions a 'progress, not perfection' mindset. Transitioning to a whole-food, plant-based diet is a major lifestyle overhaul, so full commitment might not suit everyone immediately. To foster long-term success, experts recommend easing in gradually, setting small goals, navigating social hurdles (like family dinners), and debunking myths (such as the idea that plant-based eating lacks protein).4
But wait—does this mean we can 'eat our way' out of cancer risks, or is it just one piece of a larger puzzle? And could overemphasizing diet distract from proven treatments?
What do you think? Does the idea of a plant-based diet as a cancer-fighting tool excite you, or does it raise skepticism? Share your thoughts in the comments—do you agree it's worth trying, or disagree that it could truly delay MM progression? Let's discuss!
REFERENCES
Shah UA, Cogrossi LL, Garces J, et al. A High-Fiber Plant-Based Diet in Myeloma Precursor Disorders – Results from the NUTRIVENTION Clinical Trial and Preclinical VkMYC Model. *Cancer Discov. 2025;doi:10.1158/2159-8290.CD-25-1101
A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM). ClinicalTrials.gov identifier: NCT04920084. Updated September 9, 2025. Accessed December 22, 2025. https://clinicaltrials.gov/study/NCT04920084
Gerlach A. MRD, ctDNA Testing May Help Diagnose Multiple Myeloma Precursor Conditions. Pharmacy Times. December 4, 2025. Accessed December 22, 2025. https://www.pharmacytimes.com/view/mrd-ctdna-testing-may-help-diagnose-multiple-myeloma-precursor-conditions
Memorial Sloan Kettering Cancer Center. Diets for MGUS, Smoldering Myeloma, and Multiple Myeloma: Q&A With MSK Cancer and Nutrition Experts. News release. December 8, 2025. Accessed December 22, 2025. https://www.mskcc.org/news/diets-for-mgus-smoldering-myeloma-and-multiple-myeloma-q-with-msk-cancer-and-nutrition-experts
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
